Although most of the European women’s health imaging system market will decline over the next five years, overall revenues will increase slightly as a result of growth in the breast imaging system segment, due to the introduction and adoption of more expensive and innovative systems, according to Millennium Research Group.
DENVER—Myocardial perfusion SPECT should be limited to women with indeterminate or abnormal test results, Leslee J. Shaw, PhD, co-director of the clinical cardiovascular research institute at the Emory University School of Medicine in Atlanta, said during a presentation Sept. 11 at the 16th annual American Society of Nuclear Cardiology (ASNC) scientific session. However, as Shaw reported the results of the WOMEN trial, she concluded that in the future, more of an emphasis should be placed on guiding and evaluating patients via the accepted best practice.
Using both PET and SPECT may have the potential to provide clinically useful data to enable better stratification and favorable treatments for heart failure patients.
In addition to avoiding exposure to ionizing radiation, stress cardiac MR (CMR) myocardial perfusion imaging is an effective and robust risk-stratifying tool for patients of either sex presenting with possible ischemia, according to a study in the August issue of JACC: Cardiovascular Imaging.
University Hospital Zurich has installed the Ziostation supercomputing functional analytics system from Ziosoft.
Vital, part of the Toshiba Medical Systems Group, has released Vitrea Enterprise Suite Version 6.1.
Flurpiridaz F 18 injection, a myocardial perfusion imaging (MPI) PET agent, appears to be safe and superior to SPECT with respect to image quality, diagnostic certainty and sensitivity for detection of coronary artery disease (CAD), according to a Phase II late-breaking clinical trial presented May 17 at the International Conference of Non-Invasive Cardiovascular Imaging (ICNC) in Amsterdam.
RSS 
